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Chemota ct ic migration, production of superoxide an-
ion (0 2 - ), a nd the release of ~-glucuronidase from azur-
ophilic g r a nules we r e de termined in polymorphonuclear 
leukocytes (PMN) from 135 patie nts with infectious 
(e .g . , p yoderma, acne congloba ta, e r ysipelas) as well as 
noninfectious (psoriasis) skin diseases. Purified C5a and 
th e form y lated tripeptide FMLP w e re used a s stimuli. 
In a ddi t ion, long itudina l profiles of PMN activities were 
pe rfor med a t daily inte rva ls in sev e r a l patients. Ther e 
w as a complete a bse nce of PMN responses (chemotax is, 
0 2 - -production, a nd enzy me release) specifically in-
duced by C5a in 2 5 pa tien ts suffering from various 
infla mmatory diseases of the skin. In these patients 
P MN responsiveness for t he tripeptide FMLP was either 
norma l or increased. The C5a-depe ndent defect of PMN 
was trans ie nt a nd corre la ted with disease a ctivity. 
Whe n norma l PMN w e re incuba ted with sera from C5a-
defective patients, no inhe r ent stimulatory or inhibitory 
activities compa red to control sera w er e seen. 
P r e trea tment of normal P MN in vitro with va rious 
concentrations of C5a fa iled to completely deactivate 
PMN without affecting FMLP dependent functions. 
These observations de monstrate the presence of a 
function a l defect in circulating PMN during acute c u-
taneous infla mmation. The in vitro experiments suggest 
t r a n sient blocking of C5 a -dependent P M N functions by 
a cell-bound factor w h ich seems not to be C5a or 
C5a..tcsurg-
Polymorph onuclea r leukocytes (PM N ) play an important 
ro le in inflammatory diseases assoc iated wi t h t issue da mage. 
In vitro t hese cell s demonstrate a number of functions, e.g., 
aggregation , adhesion, migration , production of oxygen radi-
ca ls, phagocytosis, and enzyme release [1] . Neutrophil activit ies 
can be t rigge red by specific chemotax ins including t he comple-
ment spli t product C5a and t he synt hetic t ripept ide FMLP 
(formyl -methionyl-Jeucyl -phenyla lanine). Both chemotaxins 
are mult ifuncti ona l in stimulating chemotax is, production of 
0 2- , as well as release of enzymes, a nd both have been used 
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C5a: complement split product C5a 
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FMLP: formyl-methionyl-leucyl-phenylalanine 
0 2-: superox ide anion production 
PBS: phosphate-buffe red saline 
P MN: polymo rphon uclear leukocytes 
ZAS: zyomosan-activaLed serum 
exte nsively in the study of PMN functions. 
In vivo regula tion of PMN function is rather complex and 
t ri ggering and inhibiting factors need to be considered. In 
addi t ion , PMN functional responses to one cytotaxin are re-
ported t o vary in inflammatory conditions, e.g., in some diseases 
chemotactic migrat ion is seen to be stimulated [2-7], whereas 
some authors have found t hese responses to be depressed [8-
11]. 
In the present study we have compared C5a-induced neut ro-
phil activities wi t h t hose elicited by FMLP in patients suffering 
from PMN -related inflammatory skin diseases. As a result a 
transient, stimulus-spec ific defect was observed demonstrating 
comp lete absence of PMN responses to C5a . This functional 
defect of PMN is disease-nonspecific and becomes ful ly re-
stored after resolution of disease. 
MATERIALS AND METHODS 
Patients 
All patients were hospita lized for severe skin condi t ions. They ac-
cepted t he proposed investigations by wri t ten consent. None of t he 
patients was under therapy when the study was started a nd t reatment. 
was applied as indicated. The cl inical diagnoses were confirmed by 
biopsy in psoriasis and pustula r psoriasis as well as by routine labora-
tory tests in patients wit h e rys ipelas, acne conglobata, and pyoderma. 
Isolation of PMN 
Neutrophils were isolated as previously described [6] us ing a slight 
modification of the method of Henson [1 2]. 
Using this technique the final ce ll preparations conta ined more than 
90% neut rophi ls wi th a viabili ty of greater t han 97% as assessed by 
t rypan blue exclusion. 
Chemotactic Factors 
Purified C5a was prepa red according to a combination of the methods 
described by Fernandez and Hugli [1 3] and Beebe et a l [14] . Briefly, 
fresh human serum was activated wi t h 20 mg/ml heat- inactivated 
baker's yeast for 30 min at 18"C. Then <-aminocaproic ac id (Sigma 
Chemical Co, Mun ich, F.R.G. ) was added to give a 1 M solut ion and 
incubated for addi t ional 1 h at 37"C. 
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Thereafte r EDTA was added to give 10 mM . Ice-cold 1 M HCI was 
added result ing in a final pH of 3.7. The solut ion was kept cold, 
centrifuged, and the supernatant diafil te red aga inst 0. 1 M a mmonium 
formate buffe r, pH 5.0, using a YM 5 ult ra fi lt ration membrane (Am icon 
Corp. Lex ington, Massachusetts). Thereafte r polyethylenglycol (M, 
8000, S igma) was added giving a final concent ration of 10%. T he 
mixture was stirred, centrifuged, a nd the supernatant applied to a CM-
cellulose column (2.6 x lO em) equi librated in 0.1 M ammonium 
fo rmate, pH 5.0. 
PMN -0 2--producing activity was eluted wi th a linear gradient of 0.5 
M ammonium formate, pH 5.0. These fractions were collected, diafil -
te red aga inst 0.1 M ammonium formate , lyophilized, and t he res idue 
applied to a Sephadex G-75 column (5.0 x 90 em), equi librated with 
0.1 M ammonium formate buffer, pH 5.0. 
Fractions inducing PMN -0 2- release were collected (M, 15,000), 
lyophilized a nd the res idue chromatographed on a CM -cellulose CM 32 
column (0.9 X 10 em) , equi librated with 0.15 M ammonium formate 
buffer, pH 5.0. The 0 2- -genera ting fractions were pooled, co ncent rated, 
diafi lte red against 0.1 M a mmonium formate (pH 7.0) and applied to a 
CM-Sephadex C-25 column (0.9 x 10 em), equi librated wi th 0.1 M 
ammonium formate, pH 7.0. C5a was eluted with the same buffe r and 
showed a s ingle line wit h sodium dodecyl sulfate-polyacryla mide gel 
electrophoresis (9%). For neut rophi l function tests , highly puri fied as 
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well as pa rt ia lly purifi ed C5a (pool of chemotactic activity after G-75 
chromatography) was so lubilized in 10-" M HCI and stored below -7o·c 
using a pool of small volumes. 
Fo rmyl-L-methionyl-L-leucyi-I. -phenylalanine (FMLP) was pur-
chased from Sigma. It was disso lved in DMSO at l0- 2 M, diluted with 
phosp hate-buffered sa line (PBS) containing 0.1 % bovine se rum albu -
min (BSA) and 0.1 glucose gtvtng a 4 X 10-" M solu tiOn, whtch was 
s tored at -7o· c in small portions. 
Chemotactic and l?an.dom Miwation. 
C h e motactic and random mi grat ion of PMN we re assayed as de-
scri bed earlier 171 or by using a mod ification of the endoge nous co m-
pone n t chemotactic assay (ECCA) method desc ribed by Crea mer eta! 
(15], however using 1:1-glucuronidase instead of lactic ac id dehydrogen-
ase as marker enzyme. 
Bot h methods apply blind-well Boyden chambers (Bio Rad, Munich, 
F.R.G.). 
Production of Superux ide Anions mz- ) 
Superox ide anion production was measured usin g a slight modifica-
tion of the method desc ribed by English et al[1 6l. In order to asce rtain 
p roper controls superoxide dismut ase (bovine blood, Sigma) was added 
to one control tube in each experiment prior to the addition of ce ll s to 
stop t he reduction of cytochrome C by o,- 1 7]. Reduced cytochrome 
C was assayed in supernatants by measurin g extinctions at 550 and 
540 nm (Hitach i 100-80 spectrophotometer) vs bl anks containing su-
perox ide di smutase at the sta rt. of the reactions. 0 2- concentrations 
we re calculated using an extinction coefficient of 15.5/ mM -em (ferro-
cytochrome c minus ferricytochrome c) [1 6]. When o,- production 
el ic ited by FMLP was measured, 5 X 105 cells per assay were used 
whe reas for C5a-dependent o,- release 2 x 106 PMN , which were 
pre incubated (10 min , 37. C) with cytochalas in B (5 11g/ ml), were used. 
Enzyme l?elease 
T h e marker enzyme of PMN azurophilic granules, 1:1-glucuronidase, 
was measured by a slight modification of the method described prev i-
ous ly [7] using p- nitrophenyl-/:i- D-g!ucuronide instead of phenolphthal-
ein-ti-D-glucuronide as substrate. A 100% co nt rol was obtained by 
addition or Triton X-1.00 (fin al concent ration: 0.1 %) instead or the 
stimulus. Release or enzy mes was expressed in percent of the Triton 
X-co nt rol (= 100%). 
RESU LTS 
Abnormalities in C5a Responsiveness of Patients ' PMN 
Dose responses for C5a- (Fig 1) a nd FMLP-induced chemo-
tax is, 0 2- release, a nd enzy me release were studied in 136 
patients with different di seases of t he skin and 46 hea lt hy 
per sons. In al l of these diseases infl ammat ion was restricted to 
skin and had started within skin. Systemic symptoms such as 
fever, arthra lgia, and high blood sedime ntation rates were seen 
in patients suffering from erys ipelas, ac ne conglobata, and 
p soriasis pustulosa. 
In a total of 25 patients , isolated peripheral neut rophils were 
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FIG l. Dose responses for chemotactic migration (e), 0 2- produc-
t io n (A) , and {:1-glucuronidase release (0) induced by C5a (abscissa ). 
PMN from hea lthy co ntrol donors we re used. 
C5A DEFECT IN LEUKOCYTE FUNCTION 195 
found to be unrespo nsive to C5a (Table 1). Absence of func-
tional respons iveness was see n when a ll t hree parameters-
chemotaxis, 0 2- production , and enzyme release-were tested. 
Furthermore this pheno menon was noted with a ll C5a concen-
trations used a nd was sti ll prese nt at a 10- to 20-fold dose 
eliciting a half maximum chemotactic respo nse (Table II ) . 
Nonstimulated (random) migration was not inhibited , indi-
cating that recep to r-dependent stimulus recogni t ion by PMN , 
but not ce llular motili ty, was a ffected . Considering t he diseases 
under investigation , t he proportion of patients demonstrating 
absence of C5a- inducible responses was highest in e rys ipelas, 
pustula r psorias is, a nd in patients suffering from widespread 
pyoderma (Table I) . On t he other hand, we were unab le to 
detect absence of dose responses in these patients when FMLP 
was used for activation of PMN function (Table II) . Instead, 
most patie nts showed increased responsiveness of PMN against 
FMLP (data not s hown). In 46 healthy con trol persons no 
evidence for functiona l PMN defects was found (Table 1). 
Longitudinal Profiles 
In a patient wit h freshly deve loping erysip elas of t he lower 
leg we examined PMN functions at near da ily intervals (Fig 2). 
In this patient PMN responses to C5a rema ined norm a l 4 h 
afte r t he pa tient beca me ill a nd showed rising body tempera-
tures. However , on the next day C5a-dependen t PMN fu nctions 
were nearly absent and t hi s included dose responses fo r the 
generation of 0 2-, chemotax is, and release of {3-glucuronidase . 
The responses to C5a were absent unt il day 6 (Fig 2). During 
this time PMN fun ctions elicited by FMLP (chemotaxis, gen-
eration of 0 2- , a nd re lease of {3-glucuronidase) rema ined unal -
tered (Fig 2) . No co rrelation was seen between body te mpera-
ture a nd the a bsence of PMN responses to C5a. 
In other patien ts we observed t his type of PMN nonrespon-
siveness lasting from 1 day to nearly 1 week (Table III ). In all 
our patients pe riods of defective PMN function were followed 
by full restoration o f C5a- induced reactions after variable 
lengths of time (one to several days). In pat ients showing 
systemic s igns such as fever , arthralgias, a nd high b lood sedi-
mentation rates, the defect appeared to last longer as compa red 
to patien ts withou t such symptoms. 
Studies with "C5a Nonresponder" Sera 
In order to further elucidate t he nat ure of C5a nonrespon-
siveness, chemotactic activity of serum samples from a ffected 
pat ien ts was tested using PMN from healthy con t rols. As can 
be seen in Fig 3, there was no inherent chemotactic activ ity in 
se ra fro m affected patients as compared to con t rol se ra or sera 
activated by zymosa n. Furthermore, neutrophil s from healt hy 
persons whe n preincubated with fresh serum from C5a nonre-
TABLE I. Number af patients with local inflammatory skin conditions 
showin!f absence of C5a -in.duced polymorphonuclear leukocy te (PM N) 
responses 
Diagnosis 
Erysipelas 
Acne conglobata 
Pyoderma 
Pso riasis vulga ris 
Psorias is pustulosa 
Urticaria vascu li tis 
Hea lthy controls 
No. of patients 
12 
9 
15 
91 
8 
1 
46 
182 
C5a-nonrespondersa 
8 
4 
6 
2 
4 
1 
0 
25 
"Meaning stimulus-spec ific absence of neut rophil responses to any 
dose of C5a (up to 800 ng/ ml ), e.g., C5a- induced chemotax is of patients' 
PMN minus random migration of patients' ce lls~ 2 SD, C5a-induced 
release of 0 2 - minus buffer cont.rol ~ 2 SD, as well as C5a-induced 
release of (3-glucuronidase minus buffer cont rol ~ 2 SO. C5a-recepto r 
specific effect is ascertained by the fact that patients ' PMN retain (a) 
cellular motility(= random migration) and (b) dose responses are seen 
with other stimuli (e.g., FMLP). 
196 SC HRODER AND CHR ISTOPHERS Vol. 85, No. 3 
TABLE ll. Poly morphonuclearleuhocyte (PMN) fu nctions in a patient with erysipelas of the lower leg 
Chemotaxis" 0 2 - -production• Enzyme release• 
Stimu lus Conccnlration (PMN x LO'/ h) (nmol red Cyt c) (% of total) 
Pati ent Control' Patient Control' Patient Control' 
C5a (ng/ ml) 800 1.8 24.5 9.0 22.2 
200 51± 3 44 ± 7 1.5 22.3 
100 50± 4 81 ± 6 1.7 17.6 
80 49 ± 3 74 ± 2 1.7 12.9 
20 47 ± 2 51± 4 1.7 3.4 
Buller 45 ± 5 29± 5 1.3 1.3 8.6 2.8 
FMLP (M) 10-G 12.2 17.5 41.0 41.7 
w-7 23 ± 3 25± 5 13.4 19.5 
10-8 48 ± 4 42 ± 5 7.0 11.1 
w-n 60 ±I 67 ± 7 1.2 1.2 
w-•o 48 ± 2 37± 5 1.4 1.2 
"Chemotactic migration as expressed in equivalents of migrated ce lls X 10'/ h using the ECCA-modification as described in Materials and 
Methods. Trip lica te experiments were done. 
1
' SD ~ma il e r than 5%. 
'PM N from a hea lthy donor, whic h were tested s imultaneously. 
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Fir: 2. Follow-up of PM N fun ction s in a patient with erys ipelas. 
For C5a (0) a nd FMLP (e), eac h point represents max imum va lues of 
dose- response curves measuring production of o,-. 
TABLE Ill. Clinical dioj.fnos is and duration of C.5a-nonresponsiuenes.~ 
in affected patients 
Diagnosis Age, Sex PMN/ Therapy• C5a defect (days )' p i" 
E rys ipelas 70, F 7,100 Erythromycin 4 
Acne congloba La l !i, M 6,800 T opica l 2 
Psorias is pustulo~a .53, M 6,300 Methotrexat e 6 
P~o rias i s vulga ri s 68, F :3,100 PUVA l 
Pyode rma 38, M 7,200 1 
Urticaria vasculi t is 42, F 2,900 7 
"Neutrophi l coun t ~ in periphem l blood at the first day of t he C5a 
defect. 
1
' Therapy has started a fter the patients were inves ti gated. 
" PMN fun ctions were te~ted in near ly daily inte rval ~ . 
spo nde rs a nd thoroughl y was hed produced normal rates of o,-
when stimul a ted with C5a (Fig 4). Also FMLP-induced re-
sponses re ma ined una lte red a nd occasionally s howed slight 
increase (data not s hown). These resul ts de monstrate, that se ra 
fro m C5a nonresponders did not conta in a ce ll-directed inhib-
itor o f C5a-elic ita bl e fun ction . 
Preincuba.Liun of PM N with C5a 
In o rde r to investigate the e ffects of preex pos ure of PMN 
with C5a, neutrophils from hea lthy controls we re incubated 
with C5a . Afte r was hin g, ce ll s we re aga in exposed to different 
co ncentra tion s of C5a o r to FMLP a nd o,- production was 
investigated. 
Fig 5 s hows t ha t, depe nding upon the co ncentrat ion of C5a 
Cells/HPF 
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F IG 3. Chemotact ic activity of patients (PS) and healthy control 
(NS) fresh serum as well as zymosa n-activated se rum of pa t ient (Z PS) 
and healthy control (ZNS), each diluted 1:30 with PBS-G B. Average 
values from tr iplicate dete rminations in 4 serum sa mples are presented. 
PMN of healthy controls were used as indicato r ce lls. 
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F IG 4. Incubation of normal PMN with nonresponcler serum (0) . 
PMN from hea lthy persons {107/ ml) were incubated (30 min /37.C) 
with fresh serum from a nonresponder patient (final dilution: 1:2), 
washed tw ice, a nd, after counting, st imulated with various concent ra-
tions of C5a for production of 0 2-. Control exper iments were performed 
by incubating PMN with 4% BSA (w/ v) (•). Six experiments of 
different patients were done. One typical experiment is shown. 
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FI G 5. Deactivat ion of C5a-dependent fun ction by preexposure wit h 
C5a. PMN from healthy cont rol persons (5 X 106/ ml ) were preincubated 
w it h C5a {linal cone: 1:2 (e ), 1:4 {X), or 1:8 {0) dilu t ion of a pool) or 
with buffer (6} in a consta nt volume (4 ml for 15 min at 37"C). Afte r 
was hing (2 x) and coun t ing of ce lls, PM N were stimul ated wi t h C5a 
and t he amoun t of 0 2- was determined. The C5a pool contained 
part ia lly purified C5a wi t h a calculated concentra tion of 300 ng/ ml. 
T h e curves describe one typical experiment. 
d uring preincubation, PMN become partially deactivated 
against subsequent stimulation by C5a. Under ident ical condi -
t ion s release of 0 2- induced by FMLP remained unaltered (data 
not shown). 
In t hese experiments we were unable to completely deactivate 
no rmal PMN by preexposure to C5a in vit ro at concent rations 
which were without effects on FMLP-dependent functions. 
DISCUSSION 
Our results show that in in!1ammatory skin diseases circu-
lating PMN may become nonresponsive to C5a while cellula r 
act ivities induced by FMLP remain unchanged. The absence 
of C5a-induced reactions persisted for variable lengths of time, 
e .g. , 1- 7 days, and thereafte r no abnon •ta lity of PMN functional 
activit ies could be detected. In no case was t here evidence t hat 
t h e rapeut ic agents were directly responsible for this defect . 
Furt hermore, this defect is seen in various inflammatory skin 
d iseases showing eit her severe courses with exte nsive body 
involvement (acne conglobata, pyoderma) and/o r vigo rous on-
set with fever and acute illness (erysipelas , pustular psoriasis). 
T his indicates that in co rrelation wi t h disease activi ty, C5a-
in duced reactions in peripheral circulating PMN may become 
a lte red resul t ing in complete nonresponsiveness to C5a. 
The reason for this defect could be a circulating factor, which 
sp ecifically a ffects C5a-dependent neut rophil fun ctions. In pa-
tien ts wi th systemic lupus erythematosus a spec ific serum 
inhibi to r of C5 fragment-derived PMN activity has been found 
[18 ]. However circulating neut rophils from these patients were 
not affected, indicating that this factor is not responsible for 
the defect desc ribed here . In a patient with allergic drug reac-
t io ns Bowers et al [19] found complement- induced reduction 
of C5 fragment-dependent granulocyte chemotaxis. Further-
m o re Skubi tz and Craddock [20] obse rved that by contact wi th 
dialyse r cellophane membranes plasma complement may be-
come act ivated via the alte rnative pathway. In t hese studies 
C5ade•mg was supposed to cause selective down regulation of 
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PMN responses to t he spli t p roduct of t he fifth complement 
component. 
Whereas such findin gs may indicate receptor-spec ific deac-
t ivation of neut rophils by circulating chemotactic C5 frag-
ments, it has been difficul t to demonstrate di rec tly the presence 
of C5a or C58dc"'"" in serum [21] . In fact in most studies (except 
studies of extracorporeal circulation) blood samples fa iled to 
show any C5ad""'"" activi t ies [21] . The most likely explanation 
for t he apparent fa ilure to detect plas ma C5 fragments is t hat 
plasma C5a or C5adesnr" rapidly binds to P MN via membrane 
receptors and becomes internali zed [22]. For t his reason 
C5ad"""'" is hardly detectable in venous blood from patients who 
were likely to have experienced activation of complement.. T his 
may serve as an explanation fo r our fa ilure to detect inherent 
chemotactic activ ity in C5a-nonresponde r sera. 
Interestingly we were unable to fully and preferent ially deac-
tivate PMN in vit ro by t reatment of PMN wit h C5a fo llowed 
by washing (Fig 5) . As shown by our experiments complete 
deactivat ion by in vit ro incubation of P M N wit h C5a could not 
be obtained withou.t affecting PMN responses to other chemo-
taxins, e.g., FMLP. Moreover a dose necessary to completely 
inhibit C5a-directed chemotaxis or 0 2- release in vit ro would 
cause nonprefe rent ial deactivation when applied in vivo, which 
is not seen in our pat ients. 
These in vi t ro results a re supported by t he !indings of Nelson 
et al [23 ]. Using a low dose of zymosan-activated se rum (ZAS) , 
t hese authors obtained only part ial deactivation of neut rophil 
chemotaxis aga inst t his chemotaxin. H owever high doses of 
ZAS caused nonpreferential deactivation. Similarly Donabe-
dian and Gallin [24] reported t hat neut roph ils incubated with 
low concent rations of C5 fragment showed only part ial inh ibi-
t ion of chemotactic activity aga inst C5 fragments. W hen high 
doses (20 J.Lg/ml) were used , again nonpreferent ial deactivation 
of subsequent chemotaxis against C5 fragments as well as 
FMLP was seen. 
In view of t hese findings it appea rs unlikely t hat deactivation 
of PMN by C5 spli t products (down regulation) is t he major 
cause for t he absence of C5a responses seen here. T his sugges-
t ion is supported by a recent ly published experimental study 
in rabbits which bea rs some similari t ies to our obse rvations in 
humans. Rosenbaum et al [25] demonstrated t hat i.v. injection 
of bacte ria l lipopolysaccha ride (endotox in ) in rabbits is fo l-
lowed by selective suppression of C5a-induced reactions in 
PMN while t he cell s retained t heir capacity to respond to 
FMLP. Similar to our observations no C5-derived chemotactic 
activi ty was seen in serum samples obtained at various t ime 
inte rvals. P lasma drawn from rabbits 24 h a fter a single i.v. 
injection of lipopolysaccharide could reduce t he chemotactic 
response of normal PMN to C5-derived chemotax ins in a 
stimulus-speci!ic manner. A factor di ffe rent from C5,., was 
suggested to be responsihle for thi s phen omenon [25]. 
Although we were unable to detect a causative factor in 
se rum , t hi s does not exclude t he ex istence of very short- lived 
fluid phase agent(s ). Ruddy et a! [26] have shown t hat t he 
alte rnative conve rtase C3bBb, which is formed from comple-
ment factors B and C3b by activation wit h D, causes deacti-
vat ion of neut rophils to subsequent stim ulation by C5,.,. T hi s 
convertase is short -lived in plasma and rapidly binds to PMN 
where it is relative ly stable. In conjunction wit h cont rol pro-
teins (e.g., factors I and H ) t his convertase may effectively 
modulate PM N responses against C5a and C5ad,'""" in vivo . 
Thus, by activation of t he alte rnative pathway of complement, 
neut rophils pass ing t he site may become nonresponsive fo r 
C5a. 
In conclusion, our observations demonstrate t hat in severe 
cutaneous inf1ammatory diso rders including psori asis C5a re-
ceptor-dependent functions of neut rophils specific fo r C5a be-
come impaired by a hi therto unknown p rinciple. T he nature of 
this effect apparent ly is related to a requirement fo r comple-
198 SC HROD ER AND CHRI STOPH ERS 
ment . T hus t he recogni t ion that C5a-dependent ce ll functions 
of PMN become modulated in acute loca l infl a mmati on may 
rep resent a novel regu lato ry mec hanism in infl ammation. Work 
in our laborato ry is in progress to ve rify this co ncept. 
We wish to thank Miss C. Gerbrecht a nd Miss C. Mehrens fo r their 
ski ll ful tec hn ica l ass istance and Mrs. I. Bottjer for typ ing the ma nu -
sc rip t. 
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